Universal Vision Biotechnology Co., Ltd. Stock
Equities
3218
TW0003218004
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 135.50 TWD | -4.24% |
|
-4.91% | -7.19% |
| Capitalization | 11.48B 365M 308M 281M 268M 498M 33.09B 515M 3.26B 1.3B 15.94B 1.37B 1.34B 55.67B | P/E ratio 2025 * |
11.4x | P/E ratio 2026 * | 8.97x |
|---|---|---|---|---|---|
| Enterprise value | 11.48B 365M 308M 281M 268M 498M 33.09B 515M 3.26B 1.3B 15.94B 1.37B 1.34B 55.67B | EV / Sales 2025 * |
2.74x | EV / Sales 2026 * | 2.59x |
| Free-Float |
51.42% | Yield 2025 * |
5.4% | Yield 2026 * | 6% |
| 1 day | -4.24% | ||
| 1 week | -4.91% | ||
| Current month | -5.24% | ||
| 1 month | -9.36% | ||
| 3 months | -6.55% | ||
| 6 months | -34.38% | ||
| Current year | -7.19% |
| 1 week | 134.5 |  | 141.5 |
| 1 month | 134.5 | | 154 |
| Current year | 134.5 | | 154 |
| 1 year | 133 | | 244.5 |
| 3 years | 133 | | 432.08 |
| 5 years | 133 | | 432.08 |
| 10 years | 18.64 | | 432.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheng Hung Lu
CEO | Chief Executive Officer | - | 2010-01-31 |
Qiu Ju Hou
DFI | Director of Finance/CFO | - | 2016-03-31 |
Pi Jung Lin
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Shu Fang Ou
CHM | Chairman | - | 2012-06-27 |
Pi Jung Lin
BRD | Director/Board Member | - | 2003-06-01 |
Min Chih Hsiao
BRD | Director/Board Member | 66 | 2012-06-27 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.24% | -4.91% | -39.64% | -57.13% | 366M | |
| +4.19% | +1.04% | -5.33% | +54.89% | 138B | |
| +0.80% | -1.21% | -25.04% | -11.58% | 38.28B | |
| -1.63% | +2.00% | -11.20% | -2.49% | 16.28B | |
| +9.71% | +14.77% | - | - | 8.94B | |
| -1.96% | +5.22% | +132.34% | +1,221.35% | 3.97B | |
| -1.08% | -2.07% | -8.70% | -57.18% | 2.05B | |
| -0.10% | +0.79% | -12.46% | -5.43% | 1.18B | |
| -0.18% | 0.00% | - | - | 918M | |
| -1.83% | +2.89% | +23.45% | -39.73% | 825M | |
| Average | +0.36% | +0.56% | +6.68% | +137.84% | 21.06B | |
| Weighted average by Cap. | +3.11% | +0.61% | -6.86% | +58.53% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.19B 133M 112M 103M 97.95M 182M 12.09B 188M 1.19B 474M 5.82B 500M 490M 20.34B | 4.43B 141M 119M 108M 104M 192M 12.77B 199M 1.26B 501M 6.15B 529M 518M 21.49B |
| Net income | 1B 31.97M 26.94M 24.59M 23.47M 43.59M 2.9B 45.08M 286M 114M 1.4B 120M 117M 4.87B | 1.28B 40.69M 34.29M 31.29M 29.87M 55.47M 3.69B 57.36M 364M 145M 1.78B 153M 149M 6.2B |
| Net Debt | - | - |
Employees
401
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-11 | 135.50 NT$ | -4.24% | 760,826 |
| 26-02-10 | 141.50 NT$ | +1.07% | 163,134 |
| 26-02-09 | 140.00 NT$ | +1.08% | 145,693 |
| 26-02-06 | 138.50 NT$ | -2.81% | 247,237 |
| 26-02-05 | 142.50 NT$ | +1.06% | 111,325 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
135.50TWD
Average target price
169.00TWD
Spread / Average Target
+24.72%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 3218 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition